Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation

Oncology Letters

Volumn 10, Issue 4, 2015, Pages 2269-2272

  Tokudome, Takatoshi ^a   Sasaki, Akiko ^a   Tsuji, Mayumi ^a   Udaka, Yuko ^a   Oyamada, Hideto ^a   Tsuchiya, Hiromichi ^a   Oguchi, Katsuji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Glioblastoma; Glioblastoma stem like cell; microRNA; Phosphatase and tensin homolog deleted on chromosome 10

Indexed keywords

CD133 ANTIGEN; MICRORNA; MICRORNA 130B 3P; MICRORNA 17 5P; MICRORNA 19A 3P; MICRORNA 19B 3P; MICRORNA 21 5P; MICRORNA 221 3P; MICRORNA 222 3P; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; RADIATION DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84940094034     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3594     Document Type: Article

References (27)

1. Blanco-Aparicio C, Renner O, Leal JF and Carnero A: PTEN, more than AKT pathway. Carcinogenesis 28: 1379-1386, 2007.
2. Carnero A, Blanco-Aparicio C, Renner O, Link W Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-198, 2008.
3. Hou W, Liu J, Chen P, Wang H, Ye BC Qiang F: Mutation analysis of key genes RAS/RAF and PTEN pathways Chinese patients with hepatocellular carcinoma. Oncol Lett 8: 1249-1254, 2014.
4. Kechagioglou Papi RM, Provatopoulou X, Kalogera E, Papadimitriou E, Grigoropoulos P, Nonni A, Zografos G, Kyriakidis DA and Gounaris A: Tumor suppressor PTEN in breast cancer: Heterozygosity, mutations protein expression. Anticancer Res 34: 1387-1400, 2014.
5. Appin CL, Gao J, Chisolm C, Torian M, Alexis D, Vincentelli C, Schniederjan MJ, Hadjipanayis C, Olson JJ, Hunter S, etal: Glioblastoma with oligodendroglioma component (GBM-O): Molecular genetic and clinical characteristics. Brain Pathol 23: 454-461, 2013.
6. Reifenberger G Collins VP: Pathology molecular genetics astrocytic gliomas. J Mol Med Berl 82: 656-670, 2004.
7. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS and Villano JL: Epidemiologic molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23: 1985-1996, 2014.
8. Qin J and Xu Q: Functions application exosomes. Acta Pol Pharm 71: 537-543, 2014.
9. Yan K, Yang K Rich JN: The evolving landscape of glioblastoma stem cells. Curr Opin Neurol 26: 701-707, 2013.
10. Dahlrot RH, Hansen S, Jensen SS, Schrøder HD, Hjelmborg J and Kristensen BW: Clinical value of CD133 nestin in patients with glioma: A population-based study. Int J Clin Exp Pathol 7: 3739-3751, 2014.
11. Kim SH, Kwon CH and Nakano I: Detoxification of oxidative stress glioma stem cells: Mechanism, clinical relevance, therapeutic development. J Neurosci Res 92: 1419-1424, 2014.
12. Hide T, Takezaki T, Nakamura H, Kuratsu J Kondo T: Brain tumor cells as research treatment targets. Brain Tumor Pathol 25: 67-72, 2008.
13. Sasaki A, Nakajo T, Tsunoda Y, Yamamoti G, Kobayashi Y, Tsuji M, Udaka Y, Mizutani T Oguchi K: Gene analysis dynamics human glioblastoma after radiation. Hum Cell 26: 73-79, 2013.
14. Lv S, Teugels E, Sadones J, De Brakeleer S, DuerinckJ, DuFour S, Michotte A, De Grève J and Neyns B: Correlation EGFR, IDH1 status with the outcome patients with recurrent treated a phase II clinical trial with EGFR-blocking monoclonal antibody cetuximab. Int J Oncol 41: 1029-1035, 2012.
15. Stechishin OD, Luchman HA, Ruan Y, Blough MD, Nguyen SA, KellyJJ, Caimcross JG Weiss S: On-target JAK2/STAT3 inhibition slows disease progression orthotopic xenografts human glioblastoma brain tumor stem cells. Neuro Oncol 15: 198-207, 2013.
16. Xie Q, Yan Y, Huang Z, Zhong X and Huang L: MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell BCNU resistance glioblastoma. Neuropathology34: 455-464, 2014.
17. Li W, Guo F, Wang P, Hong S Zhang C: miR-221/222 confers radioresistance cells through activating Akt independent status. Curr Mol Med 14: 185-195, 2014.
18. Chung JH Eng C: Nuclear-cytoplasmic partitioning phosphatase tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle apoptosis. Cancer Res 65: 8096-8100, 2005.
19. Tagawa H, Ikeda S Sawada K: Role of microRNA in pathogenesis malignant lymphoma. Cancer Sci 104: 801-809, 2013.
20. Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, et al: The miRNA-17-92 cluster mediates chemoresistance and enhances tumor growth mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia 26: 1064-1072, 2012.
21. Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM Myklebost O: Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7: e48086, 2012.
22. Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K, Yamashita J, Saitoh H, Kameoka Y, Shimizu N, etal: Aberrant overexpression microRNAs activate AKT signaling via down-regulation tumor suppressors natural killer-cell lymphoma/leukemia. Blood 114: 3265-3275, 2009.
23. Ristorcelli E, Beraud E, Verrando Villard C, Lafitte D, Sbarra V, Lombardo D Verine A: Human nanoparticles induce apoptosis pancreatic cancer cells. FASEBJ22: 3358-3369, 2008.
24. Asano T, Fujishiro M, Kushiyama A, Nakatsu Y, Yoneda M, Kamata H Sakoda H: Role phosphatidylinositol 3-kinase activation on insulin action its alteration diabetic conditions. Biol Pharm Bull 30: 1610-1616, 2007.
25. Chung JH, Ginn-Pease ME Eng C: Phosphatase tensin homologue deleted chromosome 10 (PTEN) has nuclear localization signal-like sequences for import mediated by major vault protein. Cancer Res 65: 4108-4116, 2005.
26. Liu JL, Sheng X, Hortobagyi ZK, Mao Z, Gallick GE Yung WK: Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Biol 25: 6211-6224, 2005.
27. Morales LD, Casillas Pavón EA, Shin JW, Garcia A, Capetillo M, Kim DJ Lieman JH: Protein tyrosine phosphatases PTP-1B, SHP-2, PTEN facilitate Rb/E2F-associated apoptotic signaling. PLoS One 9: e97104, 2014.